.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
QuintilesIMS
Boehringer Ingelheim
Federal Trade Commission
Dow
Daiichi Sankyo
Novartis
Cipla
Cantor Fitzgerald
Chinese Patent Office

Generated: June 22, 2017

DrugPatentWatch Database Preview

Methyprylon - Generic Drug Details

« Back to Dashboard

What are the generic sources for methyprylon and what is the scope of methyprylon freedom to operate?

Methyprylon
is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: methyprylon

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Bulk Api Vendors: see list9
Patent Applications: see list1,090
Drug Prices:see low prices
DailyMed Link:methyprylon at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche
NOLUDAR
methyprylon
TABLET;ORAL009660-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Roche
NOLUDAR
methyprylon
CAPSULE;ORAL009660-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Roche
NOLUDAR
methyprylon
TABLET;ORAL009660-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Roche
NOLUDAR
methyprylon
ELIXIR;ORAL009660-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Cipla
Healthtrust
Chinese Patent Office
McKesson
Queensland Health
Federal Trade Commission
Julphar
Baxter
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot